Bryan Johnson
member exclusive
ATN Week in Review: What’s Next for the Longevity Movement?
This week, we break down the recent controversy surrounding Peter Attia's ties to Jeffrey Epstein, and what it could mean for the future of longevity science.
member exclusive
Why the Bryan Johnson-AG1 Feud Misses What Wellness Consumers Really Care About
Wellness brands are investing heavily in scientific credibility, but consumer data suggests most people prize price and simplicity more than PhDs and peer-reviewed research.
Bryan Johnson’s Longevity Startup Raises $60M, Attracts Big-Name Investors
Bryan Johnson has raised $60 million for Blueprint as celebrity investors back his push to take longevity supplements and anti-aging services mainstream.
